Volume estimation in dialysis patients: The concordance of brain-type natriuretic peptide measurements and bioimpedance values

Hemodialysis International

Volumn 17, Issue 3, 2013, Pages 406-412

  Tapolyai, Mihály ^a   Faludi, Mária ^a   Réti, Virág ^a   Lengvárszky, Zsolt ^b   Szarvas, Tibor ^b   Fülöp, Tibor ^c   Beko, Gabriella ^a   Berta, Klára ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Bioimpedance; Dry weight; End stage renal disease; Natriuretic peptides; Volume overload

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BIOIMPEDANCE VALUE; CLINICAL ARTICLE; CLINICAL EVALUATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYDRATION; HYPERVOLEMIA; MALE; MEASUREMENT; OVERHYDRATION; PREDICTIVE VALUE; RESIDUAL URINE;

BRAIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84879693675     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12023     Document Type: Article

References (29)

1. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007; 11:21-31.
2. Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24:1574-1579.
3. Sivalingam M, Suresh M, Farrington K. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Hemodial Int. 2011; 15:359-365.
4. Raimann J, Liu L, Tyagi S, Levin NW, Kotanko P. A fresh look at dry weight. Hemodial Int. 2008; 12:395-405.
5. Thomson GE,Waterhouse K, McDonald HP Jr, Friedman EA. Hemodialysis for chronic renal failure. Clinical observations. Arch Intern Med. 1967; 120:153.
6. Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol. 2008; 3:153.
7. Agarwal R, Weir MR. Dry-weight: A concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. J Am Soc Nephrol. 2010; 5:1255-1260.
8. Katzarski KS, Nisell J, Randmaa I, Danielsson A, Freyschuss U, Bergstrom J. A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients. Am J Kidney Dis. 1997; 30:459-465.
9. Chang ST, Chen CC, Chen CL, Cheng HW, Chung CM, Yang TY. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography. Blood Purif. 2004; 22:351-359.
10. Onofriescu M, Mardare NG, Segall L, et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: Effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol. 2012; 44:583-591.
11. Voroneanu L, Cusai C, Hogas S, et al. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients Use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol. 2010; 42:789-797.
12. Biasioli S, Zamperetti M, Borin D, Guidi G, De Fanti E, Schiavon R. Significance of plasma B-type natriuretic peptide in hemodialysis patients: Blood sample timing and comorbidity burden. ASAIO J. 2007; 53:587-591.
13. Fagugli RM, Palumbo B, Ricciardi D, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003; 95:c60-c66.
14. Tapolyai M, Uysal A, Maeweathers G, Bahta E, Dossabhoy NR. B-type natriuretic peptide-directed ultrafiltration improves care in acutely hospitalized dialysis patients. Congest Heart Fail. 2009; 15:131-135.
15. Vukelic V, Peixoto AJ. Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients? Semin Dial. 2011; 24:400-402.
16. Tapolyai M, Faludi M, Reti V, Lengvarszky Z, Szarvas T, Berta K. Dialysis patients' fluid overload, antihypertensive medications, and obesity. ASAIO J. 2011 57 511-515
17. BCM-Body Composition Monitor. Operating Instructions. 2007 Edition: 7/05.10 Software version: 3,2 x Fresenius Medical Care.
18. Hanai T. Electrical properties of emulsions. In: Sherman PH, ed. Emulsion Science. London: Academic Press. 1968
19. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis. 2003; 41:1257-1266.
20. Wabel P, Moissl U, Chamney P, et al. Towards improved cardiovascular management: The necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008; 23:2965-2971.
21. Jacobs LH, van de Kerkhof JJ, Mingels AM, et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: A longitudinal study. Nephrol Dial Transplant. 2010; 25:243-248.
22. Celik G, Silinou E, Vo-Van C, Jean G, Chazot C, Plasma BNP, a useful marker of fluid overload in hospitalized hemodialysis patients. Hemodial Int. 2012; 16:47-52.
23. Chazot C, Vo-Van C, Zaoui E, et al. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant. 2011 26 2630-2634
24. House AA, Haapio M, Lentini P, et al. Volume assessment in mechanically ventilated critical care patients using bioimpedance vectorial analysis, brain natriuretic peptide, and central venous pressure. Int J Nephrol. 2010; 2011:413760.
25. Park S, Cho GY, Kim SG, et al. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care. 2009; 13:R70.
26. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003; 41:571-579.
27. Curatola G, Bolignano D, Rastelli S, et al. Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications and cardiovascular events. J Nephrol. 2011; 24:465-473.
28. Ori Y, Chagnac A, Schwartz A, et al. Non-occlusive mesenteric ischemia in chronically dialyzed patients: A disease with multiple risk factors. Nephron Clin Pract. 2005; 101:c87-c93.
29. London GM. Ultrafiltration intensification for achievement of dry weight and hypertension control is not always the therapeutic gold standard. J Nephrol. 2011; 24:395-397.